Funding for this research was provided by:
National Cancer Institute (R25CA117865, R01CA136859)
Walther Cancer Foundation (0106–01)
Indiana Clinical and Translational Sciences Institute (TR000163, TR000006)
Received: 30 March 2022
Accepted: 12 July 2022
First Online: 23 July 2022
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The studies were approved by the institutional review boards of all recruitment sites (Indiana University, Southern Illinois University School of Medicine, University of Illinois at Urbana-Champaign). Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The authors declare that they have no competing interests.